Deafness and tinnitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. This study included patients who received cochlear implants at the Auditory Implant Center of the Otorhinolaryngology-Head and Neck Surgery, China PLA General Hospital from 2011 to 2021; 2. The patients ranged from 16 to 90 years old; 3. The patient experienced hearing loss and had either tinnitus longer than 0.25 years (experimental group 1) or no tinnitus (control group 2) before the cochlear implant surgery; 4. The cochlear implants accepted by patients included products from MED-EL, Cochlear, Advanced Bionics and Nurotron; 5. All patients voluntarily participated in the study.
Exclusion criteria
Exclusion criteria: 1. Contraindications for cochlear implantation (refer to the guidelines for cochlear implantation, 2013) issued by the Chinese Medical Association; 2. Received medication to treat tinnitus at the time of cochlear implantation; 3. Cognitive impairments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tinnitus loudness;Tinnitus characteristic information; | — |
Secondary
| Measure | Time frame |
|---|---|
| mentality;sleep quality;Resting EEG;pitch matching; | — |
Countries
China
Contacts
1. College of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital; 2. National Clinical Research Center for Otolaryngologic Diseases